Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
NM_000771.4(CYP2C9):c.16G>T (p.Val6Phe)	CYP2C9	V6F	not specified	VCV003499193	10	96698455	10	94938698	3499193	3658253		NC_000010.11:94938697:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 19, 2024	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.25C>T (p.Leu9Phe)	CYP2C9	L9F	not specified	VCV003837862	10	96698464	10	94938707	3837862	3952483		NC_000010.11:94938706:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 24, 2025	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.29G>A (p.Cys10Tyr)	CYP2C9	C10Y	not specified	VCV003270585	10	96698468	10	94938711	3270585	3420147		NC_000010.11:94938710:G:A	single nucleotide variant	missense variant	Uncertain significance	May 15, 2024	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.43C>A (p.Leu15Ile)	CYP2C9	L15I	not specified	VCV002287431	10	96698482	10	94938725	2287431	2282423	rs2031306544	NC_000010.11:94938724:C:A	single nucleotide variant	missense variant	Uncertain significance	May 4, 2022	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.103C>T (p.Pro35Ser)	CYP2C9	P35S	not specified	VCV002604717	10	96698542	10	94938785	2604717	2768466	rs2493000572	NC_000010.11:94938784:C:T	single nucleotide variant	missense variant	Uncertain significance	Jun 21, 2023	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.137G>T (p.Gly46Val)	CYP2C9	G46V	not specified	VCV004008841	10	96698576	10	94938819	4008841	4125982		NC_000010.11:94938818:G:T	single nucleotide variant	missense variant	Uncertain significance	Apr 11, 2025	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.239A>T (p.Tyr80Phe)	CYP2C9	Y80F	not specified	VCV002289670	10	96701685	10	94941928	2289670	2276017	rs1259461542	NC_000010.11:94941927:A:T	single nucleotide variant	missense variant	Uncertain significance	May 25, 2022	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.250A>G (p.Lys84Glu)	CYP2C9	K84E	not specified	VCV002289671	10	96701696	10	94941939	2289671	2276018	rs1170075870	NC_000010.11:94941938:A:G	single nucleotide variant	missense variant	Uncertain significance	May 25, 2022	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.264T>C (p.Ile88=)	CYP2C9		not provided	VCV000755270	10	96701710	10	94941953	755270	768076	rs144043022	NC_000010.11:94941952:T:C	single nucleotide variant	synonymous variant	Likely benign	Jul 21, 2018	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.266A>G (p.Asp89Gly)	CYP2C9	D89G	not specified	VCV002488190	10	96701712	10	94941955	2488190	2452914	rs2493006903	NC_000010.11:94941954:A:G	single nucleotide variant	missense variant	Uncertain significance	Feb 23, 2023	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.323G>A (p.Arg108Lys)	CYP2C9	R108K	not specified	VCV003837864	10	96701769	10	94942012	3837864	3952485		NC_000010.11:94942011:G:A	single nucleotide variant	missense variant	Likely benign	Feb 1, 2025	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.356A>G (p.Lys119Arg)	CYP2C9	K119R	Warfarin response	VCV003376535	10	96701973	10	94942216	3376535	3535720		NC_000010.11:94942215:A:G	single nucleotide variant	missense variant	drug response		no assertion criteria provided							
NM_000771.4(CYP2C9):c.374G>A (p.Arg125His)	CYP2C9	R125H	not provided	VCV001167372	10	96701991	10	94942234	1167372	1156516	rs72558189	NC_000010.11:94942233:G:A	single nucleotide variant	missense variant	Benign	Aug 21, 2021	criteria provided, multiple submitters, no conflicts							
NM_000771.4(CYP2C9):c.430= (p.Arg144=)	CYP2C9			VCV000242622	10	96702047	10	94942290	242622	175331	rs1799853	NC_000010.11:94942289:C:C	single nucleotide variant	no sequence alteration	no classification for the single variant		no classification for the single variant	no classification for the single variant		no classification for the single variant	no classification for the single variant		no classification for the single variant	
NM_000771.3(CYP2C9):c.[430C>T;1075A=]	CYP2C9	R144C	Warfarin response	VCV000177709	10|10	96702047	10|10	94942290	177709	23448|175053	rs1799853|rs1057910|rs2032229276	NC_000010.11:94942289:C:T|NC_000010.11:94981295:A:A	Haplotype	missense variant|no sequence alteration	drug response	Nov 20, 2006	no assertion criteria provided							
NM_000771.3(CYP2C9):c.[430C=;1075A=]	CYP2C9		Warfarin response	VCV000163020	10|10	96702047	10|10	94942290	163020	175331|175053	rs1799853|rs1057910|rs2032229276	NC_000010.11:94942289:C:C|NC_000010.11:94981295:A:A	Haplotype	no sequence alteration	drug response	Mar 10, 2008	no assertion criteria provided							
CYP2C9*2	CYP2C9	R144C	Flurbiprofen response|Piroxicam response|Lesinurad response|not specified|not provided	VCV000008409	10	96702047	10	94942290	8409	23448	rs1799853	NC_000010.11:94942289:C:T	single nucleotide variant	missense variant	Likely benign; drug response; other	Feb 11, 2019	criteria provided, multiple submitters, no conflicts							
CYP2C9*8	CYP2C9	R150H	Lesinurad response|Flurbiprofen response|not provided|Piroxicam response	VCV000226024	10	96702066	10	94942309	226024	227771	rs7900194	NC_000010.11:94942308:G:A	single nucleotide variant	missense variant	Benign/Likely benign; drug response	Jul 3, 2023	criteria provided, multiple submitters, no conflicts							
NM_000771.4(CYP2C9):c.470G>A (p.Arg157Lys)	CYP2C9	R157K	Warfarin response	VCV003376534	10	96702087	10	94942330	3376534	3535719		NC_000010.11:94942329:G:A	single nucleotide variant	missense variant	drug response		no assertion criteria provided							
NM_000771.4(CYP2C9):c.546T>G (p.Ile182Met)	CYP2C9	I182M	not specified	VCV002283545	10	96707600	10	94947843	2283545	2273790	rs2492587460	NC_000010.11:94947842:T:G	single nucleotide variant	missense variant	Uncertain significance	Apr 13, 2022	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.622T>G (p.Leu208Val)	CYP2C9	L208V	Warfarin response	VCV000008410	10	96707676	10	94947919	8410	23449	rs72558191	NC_000010.11:94947918:T:G	single nucleotide variant	missense variant	Pathogenic	Oct 15, 2001	no assertion criteria provided							
NM_000771.4(CYP2C9):c.631C>T (p.Pro211Ser)	CYP2C9	P211S	not specified	VCV003079531	10	96707685	10	94947928	3079531	3239681	rs936448529	NC_000010.11:94947927:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2023	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.752A>G (p.His251Arg)	CYP2C9	H251R	not provided	VCV000773002	10	96708974	10	94949217	773002	701489	rs2256871	NC_000010.11:94949216:A:G	single nucleotide variant	missense variant	Benign	Mar 10, 2020	criteria provided, multiple submitters, no conflicts							
NM_000771.4(CYP2C9):c.776A>G (p.Asn259Ser)	CYP2C9	N259S	not specified	VCV003079532	10	96708998	10	94949241	3079532	3239682	rs776115064	NC_000010.11:94949240:A:G	single nucleotide variant	missense variant	Uncertain significance	Sep 22, 2023	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.787T>C (p.Phe263Leu)	CYP2C9	F263L	not specified	VCV004008842	10	96709009	10	94949252	4008842	4125983		NC_000010.11:94949251:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 30, 2025	criteria provided, single submitter							
CYP2C9*6	CYP2C9	K273fs	Lesinurad response|Flurbiprofen response|Piroxicam response|not provided	VCV000285601	10	96709039	10	94949282	285601	269838	rs9332131	NC_000010.11:94949281:AA:A	Deletion	frameshift variant	Benign/Likely benign; drug response; other	Apr 14, 2021	criteria provided, multiple submitters, no conflicts							
NM_000771.4(CYP2C9):c.820G>C (p.Glu274Gln)	CYP2C9	E274Q	not specified	VCV003837863	10	96731861	10	94972104	3837863	3952484		NC_000010.11:94972103:G:C	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2025	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.890C>T (p.Ala297Val)	CYP2C9	A297V	not specified	VCV002529625	10	96731931	10	94972174	2529625	2691569	rs1226372739	NC_000010.11:94972173:C:T	single nucleotide variant	missense variant	Uncertain significance	Mar 24, 2023	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.899A>T (p.Glu300Val)	CYP2C9	E300V	not specified	VCV003270586	10	96731940	10	94972183	3270586	3420148		NC_000010.11:94972182:A:T	single nucleotide variant	missense variant	Uncertain significance	May 20, 2024	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.907A>G (p.Ser303Gly)	CYP2C9	S303G	not specified	VCV002240869	10	96731948	10	94972191	2240869	2222523	rs1204325257	NC_000010.11:94972190:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 2, 2021	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.926C>T (p.Ala309Val)	CYP2C9	A309V	not specified	VCV003270582	10	96731967	10	94972210	3270582	3420144		NC_000010.11:94972209:C:T	single nucleotide variant	missense variant	Uncertain significance	Apr 6, 2024	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.961+729T>G	CYP2C9		Pulmonary disease, chronic obstructive, susceptibility to	VCV001693614	10	96732731	10	94972974	1693614	1686050	rs1856908	NC_000010.11:94972973:T:G	single nucleotide variant	intron variant	association	Jul 5, 2022	no assertion criteria provided							
NM_000771.4(CYP2C9):c.972G>T (p.Gln324His)	CYP2C9	Q324H	not specified	VCV004008843	10	96740950	10	94981193	4008843	4125984		NC_000010.11:94981192:G:T	single nucleotide variant	missense variant	Uncertain significance	May 21, 2025	criteria provided, single submitter							
CYP2C9*11	CYP2C9	R335W	not provided|Lesinurad response|Flurbiprofen response|Piroxicam response	VCV000370010	10	96740981	10	94981224	370010	354244	rs28371685	NC_000010.11:94981223:C:T	single nucleotide variant	missense variant	Benign/Likely benign; drug response	Jan 18, 2024	criteria provided, multiple submitters, no conflicts							
NM_000771.4(CYP2C9):c.1031A>T (p.His344Leu)	CYP2C9	H344L	not specified	VCV002532308	10	96741009	10	94981252	2532308	2699531	rs758841491	NC_000010.11:94981251:A:T	single nucleotide variant	missense variant	Uncertain significance	Apr 4, 2023	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.1075= (p.Ile359=)	CYP2C9			VCV000242623	10	96741053	10	94981296	242623	175053	rs1057910|rs2032229276	NC_000010.11:94981295:A:A	single nucleotide variant	no sequence alteration	no classification for the single variant		no classification for the single variant	no classification for the single variant		no classification for the single variant	no classification for the single variant		no classification for the single variant	
NM_000771.3(CYP2C9):c.[430C=;1075A>C]	CYP2C9	I359L	Warfarin response	VCV000163021	10|10	96741053	10|10	94981296	163021	23447|175331	rs1057910|rs1799853	NC_000010.11:94981295:A:C|NC_000010.11:94942289:C:C	Haplotype	missense variant|no sequence alteration	drug response	Nov 20, 2006	no assertion criteria provided							
CYP2C9*3	CYP2C9	I359L	Flurbiprofen response|Piroxicam response|Lesinurad response|not provided	VCV000008408	10	96741053	10	94981296	8408	23447	rs1057910	NC_000010.11:94981295:A:C	single nucleotide variant	missense variant	drug response; other	Feb 11, 2019	criteria provided, multiple submitters, no conflicts							
CYP2C9*5	CYP2C9	D360E	Lesinurad response|Flurbiprofen response|not provided|Piroxicam response	VCV000225984	10	96741058	10	94981301	225984	227774	rs28371686	NC_000010.11:94981300:C:G	single nucleotide variant	missense variant	Benign/Likely benign; drug response; other	Jan 20, 2020	criteria provided, multiple submitters, no conflicts							
NM_000771.4(CYP2C9):c.1094G>T (p.Ser365Ile)	CYP2C9	S365I	not specified	VCV003079530	10	96741072	10	94981315	3079530	3239680	rs1371272359	NC_000010.11:94981314:G:T	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2024	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.1150-1847G>A	CYP2C9		Pulmonary disease, chronic obstructive, susceptibility to	VCV001693598	10	96743943	10	94984186	1693598	1686034	rs9332220	NC_000010.11:94984185:G:A	single nucleotide variant	intron variant	association	Jul 5, 2022	no assertion criteria provided							
NM_000771.4(CYP2C9):c.1157C>A (p.Thr386Asn)	CYP2C9	T386N	not specified	VCV002263897	10	96745797	10	94986040	2263897	2249416	rs1352318689	NC_000010.11:94986039:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 3, 2021	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.1308G>T (p.Val436=)	CYP2C9		not provided	VCV000735596	10	96748620	10	94988863	735596	752341	rs199741616	NC_000010.11:94988862:G:T	single nucleotide variant	synonymous variant	Likely benign	Mar 30, 2018	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.1323C>T (p.Ala441=)	CYP2C9		not provided	VCV000776530	10	96748635	10	94988878	776530	701490	rs2017319	NC_000010.11:94988877:C:T	single nucleotide variant	synonymous variant	Benign	Jun 26, 2018	criteria provided, multiple submitters, no conflicts							
NM_000771.4(CYP2C9):c.1327A>G (p.Met443Val)	CYP2C9	M443V	not specified	VCV003270583	10	96748639	10	94988882	3270583	3420145		NC_000010.11:94988881:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 30, 2024	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.1402G>C (p.Asp468His)	CYP2C9	D468H	not specified	VCV002248533	10	96748714	10	94988957	2248533	2237952	rs1210894054	NC_000010.11:94988956:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 1, 2021	criteria provided, single submitter							
NM_000771.4(CYP2C9):c.1432T>A (p.Ser478Thr)	CYP2C9	S478T	not provided	VCV001050409	10	96748744	10	94988987	1050409	1037994	rs867786171	NC_000010.11:94988986:T:A	single nucleotide variant	missense variant	Uncertain significance		no assertion criteria provided							
